Expressed genome molecular signatures of heart failure

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 5, 2005, Pages 462-469

  Liew, Choong Chin ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GeneNews Limited   (Canada)

Author keywords

Cardiovascular diseases; Gene expression profile; Heart failure; Microarray

Indexed keywords

ALPHA ACTIN; CALMODULIN; COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; DESMIN; EARLY GROWTH RESPONSE FACTOR 1; ELASTIN; GELSOLIN; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; THYMOSIN; TROPOMYOSIN; UNCLASSIFIED DRUG;

BLOOD CELL; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; DNA MICROARRAY; EPIGENETICS; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR GENETICS; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; CONGESTIVE HEART FAILURE; EXPRESSED SEQUENCE TAG; GENETICS; GENOME; GENOMICS;

EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HEART FAILURE, CONGESTIVE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 23044453138     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.084     Document Type: Review

References (42)

1. Nabel EG. Genomic Medicine: cardiovascular disease. N Engl J Med 2003;349:60-72.
2. Goldstein JL, Brown MS. The LDL receptor defect in familial hypercholesterolemia: implications for pathogenesis and therapeutics. Med Clin N Am 1982; 66:335-62.
3. Liew CC, Hwang DM, Fung YW, Laurenssen C, Cukerman E, Lee CY. A catalogue of genes in the cardiovascular system as identified by expressed sequence tags. Proc Natl Acad Sci USA 1994;91:10645-9.
4. Hwang DM, Dempsey AA, Wang RX, Rezvani M, Barrans JD, Dai KS, et al. A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation 1997;96:4146-203.
5. Dempsey A, Dzau VJ, Liew CC. Cardiovascular genomics: estimating the total number of genes expressed in the human cardiovascular system. J Mol Cell Cardiol 2001;33:1879-86.
6. Liew CC, Dzau VJ. Human Genome Project and cardiovascular disease genes. In: Chien K, editor. Molecular basis of cardiovascular disease: a companion to Braunwald's heart disease, 2nd ed. Philadelphia: WB Saunders, 2004:16-38.
7. Dempsey AA, Pabalan N, Tang HC, Liew CC. Organization of human cardiovascular expressed genes on chromosomes 21 and 22. J Mol Cell Cardiol 2001;33:587-91.
8. Barrans JD, Ip J, Lam CW, Hwang IL, Dzau VJ, Liew CC. Chromosomal distribution of the human cardiovascular transcriptome. Genomics 2003;81:520-5.
9. Yager TD, Dempsey AA, Tang H, Stamatiou D, Chao S, Marshall KW, et al. First comprehensive mapping of cartilage transcripts to the human genome. Genomics 2004;84:524-35.
10. Holloway AJ, Van Laar RK, Tothill RW, Bowtell DD. Options available - from start to finish - for obtaining data from DNA microarrays. Nat Genet 2002;32S:481-9.
11. Gibbons GH, Liew CC, Goodarzi MO, Rotter JI, Hsueh WA, Siragy HM, et al. Genetic markers: progress and potential for cardiovascular disease. Circulation 2004; 109(Suppl 1):IV47-58.
12. Liew CC, Dzau V. Molecular genetics and genomics of heart failure. Nat Rev Genet 2004;5:1-16.
13. Friddle CJ, Koga T, Rubin EM, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA 2000;97:6745-50.
14. Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high density oligonucleotide arrays. Circulation 2000;102:3046-52.
15. Barrans JD, Stamatiou D, Liew CC. Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem Biophys Res Commun 2001; 280:964-69.
16. Tan FL Moravec CS, Li J, Apperson-Hansen C, McCarthy PM, Young JB, et al. The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 2002; 99:11387-92.
17. Boheler KR, Volkova M, Morrell C, Garg R, Zhu Y, Margulies K, et al. Sex- and age-dependent human transcriptome variability: implications for chronic heart failure. Proc Natl Acad Sci USA 2003;100:2754-9.
18. Steenman M, Chen YW, Le Cunff M, Lamirault G, Varro A, Hoffman E, et al. Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 2003;12:97-112.
19. Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000;60:1677-82.
20. Hwang JJ, Allen PD, Tseng GC, Lami CW, Lameh F, Dzau VJ, et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 2002;10:31-44.
21. Schonberger J, Seidman CE. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet 2001;69:249-60.
22. Seidman C. Hypertrophic cardiomyopathy: from man to mouse. J Clin Invest 2000;106:S9-13.
23. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995;92:1680-92.
24. Grzeskowiak R, Witt H, Drungowski M, Thermann R, Hennig S, Perrot A, et al. Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 2003;59:400-11.
25. Kapoun AM, Liang F, O'Young G, Damm DL, Quon D, White RT, et al. B-Type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 2004;94:453-61.
26. Dobson JG, Fray J, Leonard JL, Pratt RE. Molecular mechanisms of reduced β-adrenergic signaling in the aged heart as revealed by genomic profiling. Physiol Genomics 2003;15:142-7.
27. Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, Kapoun AM, et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res 2000; 86:939-45.
28. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-53.
29. Liew CC. Method for the detection of gene transcripts in blood and uses thereof. US Patent application 2002000268730, 1999.
30. Ma J, Liew CC. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol 2003;35:993-8.
31. Barnes MG, Aronow BJ, Luyrink LK, Moroldo MB, Pavlidis P, Passo MH. Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis. Rheumatology (Oxf) 2004;43:973-9.
32. Okuda T, Sumiya T, Mizutani K, Tago N, Miyata T, Tanabe T, et al. Analyses of differential gene expression in genetic hypertensive rats by microarray. Hypertens Res Clin Exp 2002;25:249-55.
33. Chon H, Gaillard CA, van der Meijden BB, Dijstelbloem HM, Kraaijenhagen RJ, van Leenen D, et al. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 2004;43:947-51.
34. Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, Nana-Sinkam SP, et al. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med 2004; 170:911-9.
35. DePrimo SE, Wong LM, Khatry DB, Nicholas SL, Manning WC, Smolich BD, et al. Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification. BMC Cancer 2003;7:3.
36. Whistler T, Unger ER, Nisenbaum R, Vernon SD. Integration of gene expression, clinical, and epidemiologic data to characterize chronic fatigue syndrome. J Transl Med 2003;1:10.
37. Tang Y, Lu A, Aronow BJ, Sharp FR. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 2001;50:699-707.
38. Tang Y, Nee AC, Lu A, Ran R, Sharp FR. Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab 2003;23:310-9.
39. Feezor RJ, Baker HV, Mindrinos M, Hayden D, Tannahill CL, Brownstein BH, et al. Inflammation and Host Response to Injury, Large-Scale Collaborative Research Program (2004). Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004;19:247-54.
40. Morello F, De Bruin TW, Rotter JI, Pratt RE, Van Der Kallen CJ, Hladik JA, et al. Differential gene expression of blood-derived cell lines in familial combined hyperlipemia. Arterioscler Thromb Vasc Biol 2004;24:2149-54.
41. Eurlings PM, Van der Kallen CJ, Geurts JM, Kouwenberg P, Boeckx WD, De Bruin TW. Identification of differentially expressed genes in subcutaneous adipose tissue from subjects with familial combined hyperlipidemia. J Lipid Res 2002;43:930-5.
42. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2005;133B:1-5.